Caxton Associates (New York)’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
PAI
RAM
GCM
Caxton Associates (New York)'s STAA Position: Q2 2024 in Review
Caxton Associates (New York) sold out of STAAR Surgical (STAA) in Q2 2024, closing a stake of 20,307 shares — an estimated $777K sold.
Caxton Associates (New York) first reported a position in STAA in Q2 2020 and held it in 3 quarters. The position peaked at $1.95M in Q4 2023. 223 funds tracked by Wall St. Rank hold STAA as of Q2 2024.
- Caxton Associates (New York) reported no remaining STAAR Surgical position as of Q2 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 20,307 STAAR Surgical shares in Q2 2024, an estimated $777K.
- Caxton Associates (New York) first reported a position in STAAR Surgical in Q2 2020 and held it in 3 quarters.
- Caxton Associates (New York)'s STAAR Surgical position peaked at $1.95M in Q4 2023.
- 223 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2024.
Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.